These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18367025)

  • 21. Use of ACE inhibition and blood pressure management in deferring dialysis initiation.
    Del Vecchio L; Teatini U; Locatelli F
    Panminerva Med; 2017 Jun; 59(2):166-172. PubMed ID: 28090762
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) Clinical Trial and Cohort Study.
    Sika M; Lewis J; Douglas J; Erlinger T; Dowie D; Lipkowitz M; Lash J; Cornish-Zirker D; Peterson G; Toto R; Kusek J; Appel L; Kendrick C; Gassman J;
    Am J Kidney Dis; 2007 Jul; 50(1):78-89, 89.e1. PubMed ID: 17591527
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease.
    Norris KC; Greene T; Kopple J; Lea J; Lewis J; Lipkowitz M; Miller P; Richardson A; Rostand S; Wang X; Appel LJ
    J Am Soc Nephrol; 2006 Oct; 17(10):2928-36. PubMed ID: 16959828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The African American Study of Kidney Disease: do these results indicate that 140/90 mm hg is good enough?
    Rahman M; El-Meanawy A; Romanello J
    Curr Hypertens Rep; 2005 Oct; 7(5):363-6. PubMed ID: 16157080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal outcomes in hypertensive Black patients at high cardiovascular risk.
    Weir MR; Bakris GL; Weber MA; Dahlof B; Devereux RB; Kjeldsen SE; Pitt B; Wright JT; Kelly RY; Hua TA; Hester RA; Velazquez E; Jamerson KA
    Kidney Int; 2012 Mar; 81(6):568-76. PubMed ID: 22189843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Blood Pressure Control on Long-Term Risk of End-Stage Renal Disease and Death Among Subgroups of Patients With Chronic Kidney Disease.
    Ku E; Sarnak MJ; Toto R; McCulloch CE; Lin F; Smogorzewski M; Hsu CY
    J Am Heart Assoc; 2019 Aug; 8(16):e012749. PubMed ID: 31411082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for progression in patients with early-stage chronic kidney disease in the Japanese population.
    Yoshida T; Takei T; Shirota S; Tsukada M; Sugiura H; Itabashi M; Ogawa T; Uchida K; Tsuchiya K; Nitta K
    Intern Med; 2008; 47(21):1859-64. PubMed ID: 18981628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood pressure, antihypertensive therapy and risk for renal injury in African-Americans.
    Kaperonis N; Bakris G
    Curr Opin Nephrol Hypertens; 2003 Jan; 12(1):79-84. PubMed ID: 12496670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood pressure components and the risk for end-stage renal disease and death in chronic kidney disease.
    Agarwal R
    Clin J Am Soc Nephrol; 2009 Apr; 4(4):830-7. PubMed ID: 19339424
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does essential hypertension cause end-stage renal disease?
    Weisstuch JM; Dworkin LD
    Kidney Int Suppl; 1992 May; 36():S33-7. PubMed ID: 1614065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease.
    Swinford RD; Portman RJ
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):143-61. PubMed ID: 15216486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome, proteinuria, and the risk of progressive CKD in hypertensive African Americans.
    Lea J; Cheek D; Thornley-Brown D; Appel L; Agodoa L; Contreras G; Gassman J; Lash J; Miller ER; Randall O; Wang X; McClellan W;
    Am J Kidney Dis; 2008 May; 51(5):732-40. PubMed ID: 18436083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estimating time to ESRD using kidney failure risk equations: results from the African American Study of Kidney Disease and Hypertension (AASK).
    Grams ME; Li L; Greene TH; Tin A; Sang Y; Kao WH; Lipkowitz MS; Wright JT; Chang AR; Astor BC; Appel LJ
    Am J Kidney Dis; 2015 Mar; 65(3):394-402. PubMed ID: 25441435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High sodium intake is associated with important risk factors in a large cohort of chronic kidney disease patients.
    Nerbass FB; Pecoits-Filho R; McIntyre NJ; McIntyre CW; Taal MW
    Eur J Clin Nutr; 2015 Jul; 69(7):786-90. PubMed ID: 25293433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid progression to end-stage renal disease in young hypertensive African Americans with proteinuria.
    Obialo CI; Hewan-Lowe K
    J Natl Med Assoc; 1998 Nov; 90(11):649-55. PubMed ID: 9828579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
    Bakris GL; Sarafidis PA; Weir MR; Dahlöf B; Pitt B; Jamerson K; Velazquez EJ; Staikos-Byrne L; Kelly RY; Shi V; Chiang YT; Weber MA;
    Lancet; 2010 Apr; 375(9721):1173-81. PubMed ID: 20170948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension in chronic dialysis patients: pathophysiology, monitoring, and treatment.
    Morse SA; Dang A; Thakur V; Zhang R; Reisin E
    Am J Med Sci; 2003 Apr; 325(4):194-201. PubMed ID: 12695724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of end stage renal disease in African Americans with lupus nephritis.
    Franco C; Yoo W; Franco D; Xu Z
    Bull NYU Hosp Jt Dis; 2010; 68(4):251-6. PubMed ID: 21162701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypertension in patients with chronic kidney disease.
    Chanda R; Fenves AZ
    Curr Hypertens Rep; 2009 Oct; 11(5):329-36. PubMed ID: 19737449
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.